About BioMedPartners
Investments are directed by BioMedPartners toward early to mid-stage companies in the life sciences sector, including diagnostics, biopharma, medical devices, and biotech. Operations center on European geographies, with typical commitments ranging from CHF2 million to CHF10 million per company. Assets under management total CHF320 million. Notable portfolio inclusions encompass Effector Therapeutics, Amplyx Pharmaceuticals, NanoString Technologies, and Affimed Therapeutics. The firm is based in Basel, Switzerland.
- Headquarter Basel, Switzerland
-
Sectors
Financial Services
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of BioMedPartners
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by BioMedPartners
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioMedPartners
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomedpartners Comparisons
Competitors of BioMedPartners
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biomedpartners
Frequently Asked Questions about BioMedPartners
Where is BioMedPartners located?
BioMedPartners is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
What does BioMedPartners do?
Investments are directed by BioMedPartners toward early to mid-stage companies in the life sciences sector, including diagnostics, biopharma, medical devices, and biotech. Operations center on European geographies, with typical commitments ranging from CHF2 million to CHF10 million per company. Assets under management total CHF320 million. Notable portfolio inclusions encompass Effector Therapeutics, Amplyx Pharmaceuticals, NanoString Technologies, and Affimed Therapeutics. The firm is based in Basel, Switzerland.